Cardiac Biomarkers Market Growth Analysis With Investment Opportunities For 2024-2033

The Business Research Company's Cardiac Biomarkers Market Growth Analysis With Investment Opportunities For 2024-2033

LONDON, GREATER LONDON, UK, August 26, 2024 /EINPresswire.com/ -- The global cardiac biomarkers market is projected to grow from $17.22 billion in 2023 to $19.48 billion in 2024, at a compound annual growth rate (CAGR) of 13.1%. The market size is anticipated to expand further, reaching $31.88 billion by 2028 at a compound annual growth rate (CAGR) of 13.1%, This growth can be attributed to increased healthcare expenditure, FDA approvals and regulatory support, an aging population, awareness programs, and the rising incidence of cardiovascular diseases.

Rising Prevalence of Cardiovascular Disorders Drives Expansion of Cardiac Biomarker Market
The rising prevalence of cardiovascular disorders is a major factor propelling the growth of the cardiac biomarker market. Cardiovascular disorders, including coronary artery disease, heart failure, and stroke, are diseases that affect the heart and blood vessels. Cardiac biomarkers, which are released into the bloodstream in response to these conditions, provide essential diagnostic and prognostic information. For example, the Centers for Disease Control and Prevention reported in May 2023 that coronary artery disease (CAD) was responsible for 375,476 deaths in 2021, underscoring the critical need for effective diagnostic tools like cardiac biomarkers.

Explore comprehensive insights into the global cardiac biomarkers market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=10234&type=smp

Key Players and Market Trends
Major companies in the cardiac biomarkers market, such as bioMerieux Inc., F. Hoffmann-La Roche AG, and Siemens AG, are focused on product innovation and expansion. For instance, Roche Diagnostics introduced five new solutions for cardiac biomarkers in April 2021, enhancing diagnostic capabilities for cardiovascular risk identification. Similarly, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. expanded its product portfolio in October 2023 by launching new high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers.

Segments:
• By Biomarkers Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types
• By Location Of Testing: Point Of Care Testing, Laboratory Testing
• By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications
• By End User: Hospitals, Specialty Clinics

Geographical Insights: North America Leads the Market
North America was the largest region in the cardiac biomarkers market in 2023, driven by the region's advanced healthcare infrastructure and high prevalence of cardiovascular diseases. The comprehensive report provides detailed insights into regional dynamics, market trends, and growth opportunities across other regions, including Asia-Pacific, Western Europe, and more.

Access the complete report for an in-depth analysis of the global cardiac biomarkers market: https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Cardiac Biomarkers Global Market Report 2024 from The Business Research Company covers the following information:
•Market size data for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Cardiac Biomarkers Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on cardiac biomarkers market size, cardiac biomarkers market drivers and trends, cardiac biomarkers market major players, cardiac biomarkers competitors' revenues, cardiac biomarkers market positioning, and cardiac biomarkers market growth across geographies. The cardiac biomarkers market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Cardiac Assist Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Valve Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn